U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07132749) titled 'NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd' on Aug. 04.
Brief Summary: This clinical trial is a prospective, observational, multicenter cohort study evaluating the efficacy and safety of NEPA (netupitant/palonosetron) in patients with HER2-positive or HER2-low advanced breast cancer treated with T-DXd
Study Start Date: Aug. 15
Study Type: OBSERVATIONAL
Condition:
Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd
Patients With HER2-low Advanced Breast Cancer Treated With T-DXd
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Yeon Hee Park
Information provided by...